HAMILTON THORNE INTRODUCES COMPREHENSIVE SUITE OF SERVICES AND SUPPORT OPTIONS
BEVERLY, MA and TORONTO, Ontario – June 16, 2014 – Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the introduction of a comprehensive suite of service plans, preventive maintenance and training offerings to support its hardware and software products.
Hamilton Thorne’s CASACare™ and LASERCare™ service plans offer economical and comprehensive coverage against unexpected repair costs and downtime. Three levels of service plans – Basic, Plus and Elite - are available for both CASA and laser systems. The three-tiered plans give customers the flexibility to choose the features that best suit their needs.
The Plus and Elite service plans include a yearly on-site Preventive Maintenance (PM) visit to help control costs and maximize performance. By proactively replacing common wear and tear parts and thoroughly checking and cleaning the system, annual PM visits increase both system life and uptime plus reduce out of pocket expense. All service plans include unlimited remote assistance and may be purchased for multiple year terms for maximum cost-effectiveness.
To complement the full-fledged service plans, Hamilton Thorne also offers on-demand services, including depot and on-site assessment and repair of equipment, preventive maintenance visits, calibration services, and hardware and software training.
“We are very excited about the release of our new CASACare and LASERCare service plans,” said David Wolf CEO of Hamilton Thorne. “These unique fixed-cost solutions build upon Hamilton Thorne’s industry leading customer support initiatives, while also continuing to build value for our shareholders through the growth of Hamilton Thorne’s business model. Important milestones like this have helped to position our product and service offering as best in class in our industry which not only helps our customers but opens up new market opportunities for the Company.”
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced imaging systems for the fertility, stem cell and developmental biology research markets. It provides novel solutions for Life Science that reduce cost, increase productivity, improve results and enable research breakthroughs in fertility, regenerative medicine, and stem cell research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses.
Hamilton Thorne’s growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.